‘Exciting’ clinical results offer hope for new class of MS therapies
PositiveScience

Exciting early results from a clinical trial in Cambridge indicate that a common diabetes drug combined with an antihistamine may help repair nerve damage associated with multiple sclerosis. Although patients may not notice significant benefits after six months, improvements in nerve function suggest a promising avenue for future therapies. This development is crucial as it offers hope for better treatment options for those affected by MS, a condition that currently has limited effective therapies.
— Curated by the World Pulse Now AI Editorial System